IP Library › Assignment 056151/0010
Patent Assignment
Reel/Frame 056151/0010

SECURITY AGREEMENT

Recorded: 2021-05-05 Received: 2021-05-05 Pages: 22
Assignors
CAVION, INC.
Executed: 2021-05-05
CELATOR PHARMACEUTICALS, INC.
Executed: 2021-05-05
JAZZ PHARMACEUTICALS, INC.
Executed: 2021-05-05
Assignee
U.S. BANK NATIONAL ASSOCIATION
100 WALL STREET, SUITE 600, NEW YORK, NY, 10005, UNITED STATES
Covered Applications (100)
CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
App. No. 17/224,781
→
GHB FORMULATION AND METHOD FOR ITS MANUFACTURE
App. No. 17/222,579
→
METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS
App. No. 17/216,540
→
METHODS AND COMPOSITIONS FOR TREATING EXCESSIVE SLEEPINESS
App. No. 17/212,079
→
GHB FORMULATION AND METHOD FOR ITS MANUFACTURE
App. No. 17/210,064
→
DELIVERY OF LOW VISCOSITY FORMULATIONS
PCTPCTUS2021019964
→
METHODS OF TREATING IDIOPATHIC HYPERSOMNIA
App. No. 17/180,991
→
METHODS OF TREATING IDIOPATHIC HYPERSOMNIA
PCTPCTUS2021019024
→
METHODS OF TREATING IDIOPATHIC HYPERSOMNIA
App. No. 63/142,738
→
FORMULATIONS OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE
App. No. 17/154,336
→
METHODS OF PROVIDING SOLRIAMFETOL THERAPY TO SUBJECTS WITH IMPAIRED RENAL FUNCTION
App. No. 17/149,406
→
GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS
App. No. 17/131,418
→
GHB DOSING
App. No. 17/130,769
→
GHB DOSING
PCTPCTUS2020066561
→
GHB FORMULATION AND METHOD FOR ITS MANUFACTURE
App. No. 17/118,041
→
FUSED BICYCLIC (HETERO)AROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF CANCERS
App. No. 17/102,621
→
TREATMENT OF HEMATOLOGICAL DISORDERS
App. No. 63/115,540
→
METHOD OF LYOPHILIZING LIPOSOMES
App. No. 17/097,530
→
METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS
App. No. 17/094,778
→
Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
App. No. 17/091,222
→
RECOMBINANT L-ASPARAGINASE
App. No. 17/078,376
→
TREATMENT METHODS USING GHB
App. No. 63/092,833
→
DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY ASSOCIATED WITH IMMUNODEPLETION
App. No. 17/046,906
→
IMMEDIATE RELEASE FORMULATIONS AND DOSAGE FORMS OF GAMMA-HYDROXYBUTYRATE
App. No. 17/067,201
→
METHODS OF TREATING IDIOPATHIC HYPERSOMNIA
App. No. 63/088,902
→
SENSITIVE DRUG DISTRIBUTION SYSTEMS AND METHODS
App. No. 17/061,783
→
TREATMENT FOR OBESITY
App. No. 17/028,674
→
NANOPARTICLE DELIVERY SYSTEMS
App. No. 17/013,101
→
CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
App. No. 17/012,831
→
CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
App. No. 17/012,823
→
METHODS OF TREATING IDIOPATHIC HYPERSOMNIA
App. No. 63/069,811
→
FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOF
App. No. 63/057,536
→
CHIRAL SYNTHESIS OF FUSED BICYCLIC RAF INHIBITORS
App. No. 63/057,531
→
GHB DOSING
App. No. 63/052,676
→
RECOMBINANT L-ASPARAGINASE
App. No. 63/047,222
→
CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
App. No. 16/916,677
→
Carbamoyl Phenylalaninol Compounds and Uses Thereof
App. No. 16/891,464
→
METHODS OF TREATMENT WITH ASPARAGINASE
App. No. 16/767,920
→
METHODS AND COMPOSITIONS FOR TREATING EXCESSIVE SLEEPINESS
App. No. 16/877,717
→
GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISORDERS
App. No. 15/930,295
→
DEFIBROTIDE TREATMENT FOR THE PREVENTION OF ORGAN REJECTION AND INJURY
App. No. 63/011,645
→
GHB DOSING
App. No. 63/000,547
→
METHODS OF TREATING IDIOPATHIC HYPERSOMNIA
App. No. 62/993,381
→
SENSITIVE DRUG DISTRIBUTION SYSTEMS AND METHODS
App. No. 16/826,909
→
GHB DOSING
App. No. 62/993,372
→
METHODS OF PROVIDING SOLRIAMFETOL THERAPY TO SUBJECTS WITH IMPAIRED RENAL FUNCTION
App. No. 16/824,560
→
DELIVERY OF LOW VISCOSITY FORMULATIONS
App. No. 62/983,023
→
METHODS OF TREATING IDIOPATHIC HYPERSOMNIA
App. No. 62/979,667
→
CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF
App. No. 16/634,935
→
GHB DOSING
App. No. 62/953,288
→
CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
App. No. 16/712,260
→
SUBCUTANEOUS DELIVERY OF HIGH CONCENTRATION FORMULATIONS
PCTPCTUS2019064901
→
METHODS AND COMPOSITIONS FOR TREATING EXCESSIVE SLEEPINESS
App. No. 16/618,735
→
ALCOHOL-RESISTANT DRUG FORMULATIONS
App. No. 16/688,797
→
ALCOHOL-RESISTANT DRUG FORMULATIONS
PCTPCTUS2019062237
→
Antagonists of Products of the HS.459642 Unigene Cluster for the Inhibition of Proliferation, Development or Differentiation of Stem Cells Including Cancer Stem Cells
App. No. 16/685,279
→
RECOMBINANT L-ASPARAGINASE
App. No. 62/926,201
→
METHODS FOR TREATING DRAVET SYNDROME
App. No. 16/608,355
→
METHODS FOR IMPROVING MEMORY AND COGNITION AND FOR TREATING MEMORY AND COGNITIVE DISORDERS
App. No. 16/608,401
→
TREATING ESSENTIAL TREMOR USING (R)-2-(4-ISOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)ETHYL)ACETAMIDE
PCTPCTUS2019054498
→
CALCIUM CHANNEL INHIBITORS
App. No. 16/486,399
→
DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY ASSOCIATED WITH IMMUNODEPLETION
PCTPCTUS2019027210
→
Carbamoyl Phenylalaninol Compounds and Uses Thereof
App. No. 16/338,925
→
TREATMENT OF CATAPLEXY
App. No. 16/359,446
→
Solvate Form of (R)-2-amino-3-phenylpropyl carbamate
App. No. 16/331,069
→
METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS
App. No. 16/245,067
→
METHOD OF USING GAMMA-HYDROXYBUTYRATE COMPOSITIONS FOR THE TREATMENT OF DISORDERS
App. No. 16/230,460
→
FORMULATIONS OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE
App. No. 16/225,890
→
Modified L-Asparaginase
App. No. 16/226,499
→
METHOD OF LYOPHILIZING LIPOSOMES
App. No. 16/181,203
→
TREATMENT FOR OBESITY
App. No. 16/144,247
→
HIGH CONCENTRATION FORMULATIONS
App. No. 16/105,319
→
CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF
PCTPCTUS2018044465
→
COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS
App. No. 16/048,100
→
SENSITIVE DRUG DISTRIBUTION SYSTEMS AND METHODS
App. No. 16/032,501
→
INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)
App. No. 16/069,092
→
CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
App. No. 16/025,487
→
METHODS AND COMPOSITIONS FOR TREATING EXCESSIVE SLEEPINESS
PCTPCTUS2018035532
→
METHODS FOR TREATING ANGELMAN SYNDROME AND RELATED DISORDERS
App. No. 15/769,980
→
METHOD OF LYOPHILIZING LIPOSOMES
App. No. 15/891,170
→
IMPROVED NANOPARTICLE DELIVERY SYSTEMS
App. No. 15/744,723
→
METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS
App. No. 15/869,792
→
CARBAMOYL PHENYLALANINOL COMPOUNDS AND USES THEROF
PCTPCTUS2017055598
→
DEVICES AND METHODS FOR FACILITATING AND CONTROLLING USE OF A MEDICATION
App. No. 15/714,456
→
SOLVATE FORM OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE
PCTPCTUS2017050233
→
FORMULATIONS OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE
PCTPCTUS2017050221
→
FORMULATIONS OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE
App. No. 15/695,913
→
Modified L-Asparaginase
App. No. 15/671,086
→
TREATMENT FOR OBESITY
App. No. 15/594,070
→
FUSED BICYCLIC (HETERO)AROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF CANCERS
App. No. 15/509,952
→
TREATMENT OF CATAPLEXY
App. No. 15/419,133
→
GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISORDERS
App. No. 15/385,447
→
TREATMENT OF CATAPLEXY
App. No. 15/149,478
→
SENSITIVE DRUG DISTRIBUTION SYSTEM AND METHOD
App. No. 15/057,898
→
GHB FORMULATION AND METHOD FOR ITS MANUFACTURE
App. No. 15/047,586
→
SENSITIVE DRUG DISTRIBUTION SYSTEM AND METHOD
App. No. 15/014,831
→
COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS
App. No. 14/990,167
→
TREATMENT FOR OBESITY
App. No. 14/955,646
→
METHODS OF MAKING A MIXTURE OF SALTS OF GAMMA-HYDROXYBUTYRATE
App. No. 14/821,384
→
METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS
App. No. 14/707,914
→